ABIE:XETRA:XETRA-AXA IM ACT Biodiversity Equity UCITS ETF EUR(H) Acc (EUR)

ETF | Others |

Last Closing

USD 11.982

Change

-0.06 (-0.53)%

Market Cap

N/A

Volume

4.20K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-17 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.21 (+0.42%)

USD 450.46B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.08 (+0.51%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.13 (+0.50%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.27 (+0.99%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.04 (-0.17%)

USD 157.79B
TM5:XETRA T-MOBILE US INC.DL-00001

-1.02 (-0.66%)

USD 126.93B
8R80:XETRA Amundi Index Solutions - Amund..

-0.56 (-0.40%)

USD 104.09B
JARI:XETRA Amundi Index Solutions - Amund..

-0.25 (-0.58%)

USD 101.29B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.28 (+0.55%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-1.10 (-0.22%)

USD 80.38B

ETFs Containing ABIE:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.85% 45% F 48% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.85% 45% F 47% F
Trailing 12 Months  
Capital Gain 8.71% 58% F 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.71% 58% F 60% D-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 2.76% 46% F 45% F
Dividend Return 2.76% 45% F 43% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 5.48% 82% B 86% B+
Risk Adjusted Return 50.43% 64% D 67% D+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.